Theralink Technologies, Inc. (THER)

OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Feb 18, 2026
-99.00%
Market Cap 6.15K
Revenue (ttm) 635.45K
Net Income (ttm) -13.50M
Shares Out 6.15B
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,500,000
Average Volume 478,739
Open 0.0000
Previous Close 0.0000
Day's Range 0.0000 - 0.0000
52-Week Range 0.0000 - 0.0010
Beta 65.19
RSI 43.15
Earnings Date n/a

About Theralink Technologies

Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of oncology products in the United States. The company offers patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It also provides precision oncology data through its Theralink Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying... [Read more]

Industry Biotechnology
Sector Healthcare
Employees 16
Stock Exchange OTCMKTS
Ticker Symbol THER
Full Company Profile

Financial Performance

In fiscal year 2023, Theralink Technologies's revenue was $606,796, an increase of 6.85% compared to the previous year's $567,905. Losses were -$30.95 million, 138.4% more than in 2022.

Financial Statements

News

There is no news available yet.